|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2481753 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11192240.7 |
| Date of filing the European patent application | 2006-12-05 | |
| (97) | Date of publication of the European application | 2012-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-18 |
| (46) | Date of publication of the claims translation | 2018-05-25 |
| (30) | Number | Date | Country code |
| 749953 P | 2005-12-13 | US | |
| 801948 P | 2006-05-19 | US |
| (72) |
Allan, Barrett, US
Chow, Chi-kin, US
Huang, Lihua, US
Liu, Ling, US
Lu, Jirong, US
Ng, Kingman, US
Tetreault, Jonathan Wendell, US
Werner, Andrew Gordon, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Anti-IL-17 antikūnai |
| Anti-IL-17 Antibodies |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 19 | 347.00 EUR |
| 2025-12-05 |